Switching from reference adalimumab to biosimilar. Assessment of clinical outcomes in psoriasis

Saved in:
Bibliographic Details
Published in:International journal of dermatology 2023-03, Vol.62 (3), p.e159-e161
Main Authors: Ruiz‐Villaverde, Ricardo, Velasco‐Amador, Juan Pablo, Prados‐Carmona, Alvaro, Ruiz‐Carrascosa, Jose Carlos
Format: Article
Language:English
Subjects:
Adalimumab
Biosimilar Pharmaceuticals
Humans
Monoclonal antibodies
Psoriasis
Skin diseases
Treatment Outcome
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0011-9059
1365-4632
DOI:10.1111/ijd.16399